The aim of the study was to elucidate the role of hyperinsulinaemia/insulin resistance in hypertension of lean postmenopausal women. Twenty-four women with essential hypertension (systolic/diastolic у140/90 mm Hg) and a body mass index (BMI) less than 26 kg/m 2 not receiving antihypertensive treatment or who had been without treatment for a 4-week washout period, and 10 normotensive postmenopausal weight-and aged-matched controls were compared. Both groups were not receiving hormone replacement therapy. Hip and waist circumferences were measured and waist/hip ratios were calculated. Casual blood pressure was measured in triplicate. Neither the fasting plasma glucose nor serum insulin levels in hypertensive women and normotensives differed significantly. During 2 h oral glucose (75 g)-tolerance test the mean plasma glucose levels after 30 min (172.5 ± 40.24 mg/dl vs 143.67 ± 20.16 mg/dl), 60 min (134.88 ± 38.78 mg/dl vs 112.33 ± 5.44 mg/dl) and 120 min (116.08 ± 26.65 mg/dl vs 95.56 ± 20.17 mg/dl) were significantly higher in hypertensives than that for normotensives (P Ͻ 0.05 for all three comparisons). The mean serum insulin levels of hypertensive women were significantly higher than that in normotensives after 15 min (92.04 ± 59.90 U/ml vs 54.89 ± 33.67 U/ml) and 120 min (49.63 ± 44.45 U/ml
Introduction
Diseases of the heart and the blood vessels such as heart attack and stroke (cardiovascular diseases) have traditionally been considered as a condition predominately affecting men. However, in recent years, it has become increasingly evident that this belief is inaccurate. One-third of women between the ages of 50 and 75 years have cardiovascular disease, which accounts for more than 50% of all deaths among women annually. Cardiovascular diseases which includes coronary heart disease and stroke not only are the leading cause of death among women; they are more lethal and less aggressively treated in women than in men. 1, 2 Hypertension is one of the major risk factors for the development of 26 U/mg) (P Ͻ 0.05 for all three comparisons). Significant correlations were observed between the daytime period and 24-h average ambulatory systolic blood pressure and the area under the serum insulin curve (r = 0.41 and 0.36, respectively). For non-dippers we found higher fasting insulinaemias but the AUC insulin did not differ. Plasma glucose levels did not differ either during fasting or during OGTT (AUC glucose ). Insulinogenic index was higher in dippers than in non-dippers. We conclude that in lean, postmenopausal hypertensive women insulin resistance is increased compared with age-and weightmatched normotensive women. Also, hyperinsulinaemia correlates with ambulatory systolic blood pressure. Thus, insulin resistance may possibly be involved as a pathogenetic factor in lean, postmenopausal hypertensive women. Journal of Human Hypertension (2002) 16 (Suppl 1), S145-S150. DOI: 10.1038/sj/jhh/1001362 cardiovascular disease in women. According to the Third National Health and Nutrition Examination Survey (NHANES III), about 50% of all hypertensive patients are women, and among elderly women up to 80% suffer from hypertension. 3 In the Framingham Heart Study clusters of three or more risk factors were associated with a 2.39 and 5.90 times greater risk of coronary heart disease in men and women, respectively. 4 There is a 'sexual dimorphism' in blood pressure: women with functional ovaries tend to have lower blood pressures than men, whereas menopause or ovariectomy tends to abolish the sexual dimorphism and cause women to develop a 'male pattern of blood pressure'. 5 What does seem likely is that aging and gradual oestrogen deficiency contribute to the increased risk of cardiovascular disease in older women. On the other hand there does seem to be a relationship between premature menopause, or surgically induced menopause (ie, hysterectomy with bilateral oophorectomy) and increased incidence of cardiovascular disease morbidity and mortality. Premature menopause, occurring before age 35, has been associated with a two-to three-fold increased risk of myocardial infarction; oophorectomy before age 35 increased the risk seven-fold. Earlier prospective studies have shown that weight gain is common for women at the time of menopause. 6 Previous studies disagree as to whether the menopausal transition is related to an increase in blood pressure that is independent of other concomitant changes in risk factor levels, such as weight and/or central fat patterning. Increases in both systolic and diastolic blood pressure (DBP) during menopause have been found in overweight women. 7 On the other hand, menopause per se has been suggested to potentiate the agerelated increase in systolic blood pressure (SBP). 8, 9 Whether postmenopause alone is accompanied by a plurimetabolic syndrome still remains unsolved. In a recent study in 8437 non-diabetic Chinese patients hypertension was linked to the metabolic syndrome in women only. 10 It is controversial whether insulin resistance causes hypertension.
This study was designed to evaluate the following questions. To what extent is hypertension in lean naturally postmenopausal women 'per se' able to develop hyperinsulinaemia and insulin resistance? What is the relationship of fasting serum insulin levels and those measured during an oral glucose-tolerance test (OGTT) with office blood pressure and ambulatory blood pressure? Is there a relationship between the circadian profile of blood pressure and hyperinsulinaemia and insulin resistance?
Subjects and methods
This study included 24 naturally postmenopausal uncomplicated ambulatory women (mean age 57 ± s.d. 6 years) with essential hypertension (office seated diastolic blood pressure 95-110 mm Hg on three or more measurements during at least two clinic visits, as well as a history of hypertension) and a body mass index (BMI) of 24.22 kg/m 2 and 10 normotensive postmenopausal weight-and agedmatched controls (mean age 61 ± 8 years), and a BMI of 24.16 ± 2.89 kg/m 2 . Written informed consent to participate in our study was required from each patient, and the study was approved by the Ethics Committee of Buenos Aires School of Medicine. Patients had either never been treated or had discontinued all antihypertensive medication for at least 4 weeks before the study and they did not receive any pharmacologic treatment for dislipidaemia. Exclusion criteria were secondary hypertension, type 1 or type 2 diabetes mellitus, alcoholism, and serious cardiopulmonary, renal and hepatic diseases. Natural postmenopausal status was confirmed by amenorrhoea of at least 6 months duration, a follicle stimulating hormone level Ͼ40 IU/l, and an oestradiol concentration Ͻ100 pmol/l. Both groups were not receiving hormone replacement therapy.
Waist and hip circumferences were measured by one observer by means of a steel tape. OGTT was performed according to the recommendations of the National Diabetes Data Group, 11 namely with 75 g glucose per adult regardless of body size, dissolved in 150 ml water, administered in 5 min. During the week preceding this test, an isoenergetic diet containing 200 mg NaCl/day was prescribed. No eating or smoking was allowed after 8.00 pm on the day preceding the test. They were told not to engage in any significant physical activity before testing. The OGTT was started between 7.30 and 8.30 am. Plasma glucose and insulin concentrations in venous blood samples drawn from an indwelling antecubital venous catheter or needle were measured before and 15, 30, 60 and 120 min after glucose ingestion. Plasma glucose level was measured by means of the glucose oxidase method. Immunoreactive insulin was assayed in serum using a radioimmunoassay kit (Linco Laboratory, Miami, FL, USA). 12 The lowest limit of detection of the assay was 15 pmol/l (25 U/ml) with an intra-assay coefficient of variation equal to 11.5%. This assay did not have a cross-reaction with human proinsulin. The assay's sensitivity limit was 2 U/ml. Total cholesterol and triglyceride levels were measured by means of enzymatic techniques (Boehringer Mannheim, Mannheim, Germany) in a Monarch analyzer (instrumentation Laboratory, Lexington, MA, USA). High-density lipoprotein lipoprotein (HDL) cholesterol level was measured after precipitation of low-density lipoprotein (LDL) cholesterol with Mg SO 4 and dextrose. Within 48 h of OGTT, always on a working day, under the recommendations of continuing their diets and habitual activities, 24 h ambulatory blood pressure monitoring was performed. All subjects were instructed to rest or sleep between 11.00 pm and 7.00 am. A portable Takeda TM 2421 (A&D, Higashi-lkeburo, Tokyo, Japan) blood pressure and heart rate device provided with a cuff was adapted to fit the patient's left arm and was programmed to record blood pressure and heart rate at 15-min intervals during the 7.00 am to 11 pm daytime period and at 30-min intervals during the 11.00 pm to 7.00 am night-time period. Women who stated that they had not rested between 11.00 pm to 7.00 am were not included. The patients who exhibited falls (Ͼ10%) in SBP and DBP corresponding to the 95th percentile of a normotensive population) during the time period 11.00 pm to 7.00 am with respect to the values for 7.00 am to 11.00 pm were classified as dippers, all those not exhibiting this characteristic being considered non-dippers. Twenty-four hour mean SBP heart rate (pressurerate) product for every patient was calculated from the ambulatory data as SBP × heart rate/100 (units).
The areas under the blood glucose curve (AUC glucose ), serum insulin curve (AUC insulin ) and insulin/glucose ratio (AUC insulin/glucose ratio ) were calculated using the trapezoidal integration. The mean insulin value was employed for estimation of insu-S147 lin response to the OGTT, and is equal to 2 h insulin area (estimated by trapezoid rule) divided by 120 min. 13 Fasting serum insulin and mean values of serum insulin were transformed into log 10 respectively, so as to normalise their distribution in these analyses. The mean plasma fasting glucose and insulin (IRI), insulinogenic index (ratio of the increment of the insulin level to that of glucose level between 0 and 30 min after the OGTT) and ⌺IRI (the sum of the plasma insulin levels 0, 30, 60 and 120 min after the OGTT) of both groups were compared. In addition, the homeostasis model insulin resistance index (Homa's index) a candidate for the simple assessment of insulin sensitivity, was calculated using the formula: fasting plasma glucose (mg/dl) × fasting IRI (U/ml) Ϭ 405 14 and the mean indices of the groups were compared.
All the data are expressed as mean ± s.d. Comparisons between the two groups were performed by one-way analysis of variance (ANOVA) and the Student-Newman-Keuls test. When variances were similar, one-tailed Student's t-test for independent samples was applied. If the variances differed, we used the Smith Satterhwaite procedure to estimate the approximate number of degrees of freedom. P Ͻ 0.05 was considered statistically significant.
Results
The main clinical characteristics and lipid profile of both groups are reported in Table 1 . Age did not differ between the two groups. In postmenopausal women with essential hypertension total cholesterol:HDL cholesterol index was significantly higher than it was for those in the normotensive group. There were no significant differences in serum total cholesterol between the two groups. HDL choles- terol was lower and triglycerides were higher in the hypertensive group. Table 2 presents ambulatory blood pressure data for both studied groups. We found no significant difference in heart rate but the heart rate-SBP was higher in the hypertensive group. Neither the fasting plasma glucose nor fasting serum insulin levels in members of the two groups differed significantly. During the OGTT the glucose levels after 30 min (172.5 ± 40.24 mg/dl vs 143.67 ± 20.16 mg/dl), 60 min (134.88 ± 38.78 mg/dl vs 112.33 ± 5.44 mg/dl) and 120 min (116.08 ± 26.65 mg/dl vs 95.56 ± 20.17 mg/dl) were significantly higher in hypertensives than that for normotensives (P Ͻ 0.05 for all three comparisons; Figure 1 ). The mean serum insulin levels of hypertensive women were significantly higher than that in normotensives after 15 min (92.04 ± 59.90 U/ml vs 54.89 ± 33.67 U/ml) and 120 min (49.63 ± 44.45 U/ml vs 19.22 ± 24.10 U/ml; P Ͻ 0.05 for both comparisons, Figure  2 ). The mean serum insulin:plasma glucose ratio for hypertensive women was significantly higher than that for normotensives after 15 min (0.596 ± 0.46 vs Figure 1 Plasma levels of glucose. Figure 3 ). In the hypertensive group Homa's index and ⌺IRI were higher than in normotensives (3.82 ± 1.05 vs 2.45 ± 1.33, and 212.96 ± 83.27 vs 153 ± 75.11, respectively, both of them P Ͻ 0.05), while the insulinogenic index was not significantly different. The incidence of hypertension in the hyperinsulinaemic group (fasting insulinaemia у15 or ⌺IRI у150 U/ml) was significantly higher than that in the normoinsulinaemic group (fasting insulinaemia Ͻ10 or ⌺IRI Ͻ150 U/ml). Significant correlations were observed between the daytime period and 24-h average ambulatory SBP and the area under the serum insulin curve (r = 0.41 and 0.36, respectively), and ⌺IRI (r = 0.43 and 0.39, respectively).
There were 18 dipper and six non-dippers. Mean age, waist:hip ratio, casual DBP, 24-h averages of SBP and DBP, 7.00 am to 11.00 pm SBP, and 24-h average heart rate-SBP product for dippers were significantly lower than those for non-dippers. Table  3 shows the anthropometric and metabolic data, and the 24-h ambulatory blood pressure measurements. Age, height, and waist:hip ratio, 24-h averages of SBP and DBP, 7.00 am to 11.00 pm SBP and 24-h average heart rate-SBP product for dippers were significantly lower than those for non-dippers. For non-dippers we found higher fasting insulinaemias but the AUC insulin did not differ. Plasma glucose levels did not differ either during fasting or during OGTT (AUC glucose ). Insulinogenic index was higher in dippers than in non-dippers.
Discussion
The current results show that lean, postmenopausal hypertensive women have higher levels of glycaemia and insulinaemia during OGTT and insulin AUC than do those lean postmenopausal normotensive women. The insulin:glucose ratio, a crude index of insulin sensitivity, the HOMA's index (a candidate for the simple assessment of insulin sensitivity) and ⌺IRI were higher in the hypertensive group suggesting that lean postmenopausal hypertensive women are already insulin-resistant. Also, hyperinsulinaemia correlates with ambulatory SBP. Thus, insulin resistance may possibly be involved as a pathogenic factor in lean, postmenopausal hypertensive women. However, the hypothesis that hyperinsulinaemia plays an etiopathogenic role in essential hypertension is not universally accepted, because not every hypertensive patient exhibits insulin resistance and not all people with insulin resistance suffer from hypertension. Impairment of carbohydrate metabolism occurs with increasing prevalence as a function of aging. It has been proved that, even for non-obese normotensives, aging is associated with a decrease in insulin sensitivity. 15 Nevertheless, in the present study we could not attribute the differences observed between hypertensive and normotensive postmenopausal women to the confounding effect of age, because there was no difference in that variable between them. Although some studies in general population of both sex, found a direct relationship between serum insulin levels, adjusted for age and body fat distribution and blood pressure, [16] [17] [18] others did not report any correlation between these parameters. 19 Moreover, the insulin sensitivity index obtained with the euglycaemic clamp and the 2-h insulin level of the OGTT were more closely related correlated to ambulatory blood pressure recordings than was the fasting insulin level. 20 With our small sample of a hypertensive population we found correlation between the daytime period and 24-h average ambulatory SBP and the area under the serum insulin curve. It is accepted nowadays that the area below the insulin profile during an OGTT is an index of pancreatic ␤-cell functioning and it is significantly correlated to insulin resistance in non-diabetic patients. 21 It is accepted that the non-dipper behaviour of blood pressure is associated with a high risk of cardiovascular complications. 22 We observed no significant difference in the AUC of plasma glucose, serum insulin and insulin: glucose ratio between these two types of circadian behaviour of blood pressure. It has been shown in previous studies that the insulinogenic index, which may reflect S149 the early response of insulin secretion to glucose loading, declined as the glucose tolerance changed from normal to a diabetic pattern. 23, 24 In our study we observed that non-dippers had a lower insulinogenic index than dippers. Thus, it appears that the impairment of insulin sensitivity has a relationship with disturbances in noctumal fall in blood pressure in postmenopausal hypertensive women.
When the possible reasons for the increase in cardiovascular disease in postmenopausal women are examined, the most prevalent finding is that total cholesterol rises at an accelerated rate after menopause. Whereas age-related changes in weight, blood pressure, and blood glucose levels are not thought to be substantially different in men and women, the rate of elevation of total cholesterol results from increases in levels of LDL-cholesterol (LDL-C), with the more dense forms predominating, and increases in very-low density lipoprotein (VLDL) and lipoprotein a (LP(a) ). The oxidation of LDL-C is also enhanced. HDL-cholesterol (HDL-C) levels may Journal of Human Hypertension decrease over time, but these changes are small and insignificant relative to the increases in LDL-C. Previous evidence showed that insulin resistance and compensatory hyperinsulinaemia were associated with lower HDL-cholesterol and higher fasting and posprandial triglyceride levels. 25 It was predicted that the more insulin-resistant an individual, the greater would be the untoward metabolic effects of a low-fat, high-carbohydrate diet. 26 The serum lipid profile observed in lean postmenopausal women with essential hypertension-triglyceride levels and total cholesterol:HDL-cholesterol higher than the normotensive group, define subjects at higher risk for developing cardiovascular diseases. 27, 28 In conclusion, the results of the current study suggest that hypertension 'per se' is associated with hyperinsulinaemia and insulin resistance, and it seems that there is a weak correlation between the circadian profile of blood pressure and hyperinsulinaemia and insulin resistance in lean postmenopausal women.
